Bone morphogenetic proteins in breast cancer: Dual role in tumourigenesis?

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages

  Alarmo, Emma Leena ^a   Kallioniemi, Anne ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 8; BONE MORPHOGENETIC PROTEIN RECEPTOR; GROWTH DIFFERENTIATION FACTOR 9; GROWTH DIFFERENTIATION FACTOR 9A; OSTEOGENIC PROTEIN 1; OSTEOGENIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE METASTASIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE ARREST; CELL GROWTH; CELL MIGRATION; HUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SIGNAL TRANSDUCTION;

EID: 77953590859     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0273     Document Type: Review

References (171)

1. Alarmo EL, Rauta J, Kauraniemi P, Karhu R, Kuukasjarvi T & Kallioniemi A 2006 Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes, Chromosomes and Cancer 45 411-419.
2. Alarmo EL, Kuukasjarvi T, Karhu R & Kallioniemi A 2007 A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Research and Treatment 103 239-246.
3. Alarmo EL, Korhonen T, Kuukasjarvi T, Huhtala H, Holli K & Kallioniemi A 2008 Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Annals of Oncology 19 308-314.
4. Alarmo EL, Parssinen J, Ketolainen JM, Savinainen K, Karhu R & Kallioniemi A 2009 BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Letters 275 35-43.
5. Albertson DG 2006 Gene amplification in cancer. Trends in Genetics 22 447-455.
6. Albertson DG, Collins C, McCormick F & Gray JW 2003 Chromosome aberrations in solid tumors. Nature Genetics 34 369-376.
7. Anderson E 2002 The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Research 4 197-201.
8. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M & Miyazono K 2001 Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. Journal of Cell Science 114 1483-1489. (Pubitemid 32427835)
9. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S & Fujisawa Y 1995 Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochemical and Biophysical Research Communications 210 670-677.
10. Arnold SF, Tims E & Mcgrath BE 1999 Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine 11 1031-1037.
11. Attisano L & Labbe E 2004 TGFb and Wnt pathway cross-talk. Cancer Metastasis Reviews 23 53-61.
12. Attisano L & Wrana JL 2000 Smads as transcriptional co-modulators. Current Opinion in Cell Biology 12 235-243.
13. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE & Hamdy FC 1998 Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. British Journal of Cancer 78 1219-1223. (Pubitemid 28479155)
14. Balemans W & Van Hul W 2002 Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Developmental Biology 250 231-250.
15. Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS & Lian JB 2003 Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. Journal of Cellular Biochemistry 89 401-426.
16. Barbara NP, Wrana JL & Letarte M 1999 Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. Journal of Biological Chemistry 274 584-594. (Pubitemid 129535212)
17. Barnes GL, Hebert KE, Kamal M, Javed A, Einhorn TA, Lian JB, Stein GS & Gerstenfeld LC 2004 Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Research 64 4506-4513.
18. Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ et al. 2007 Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Research 67 8149-8155.
19. Botchkarev VA 2003 Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. Journal of Investigative Dermatology 120 36-47.
20. von Bubnoff A & Cho KW 2001 Intracellular BMP signaling regulation in vertebrates: pathway or network? Developmental Biology 239 1-14.
21. Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, ten Dijke P, Cleton-Jansen AM, Driouch K et al. 2007a Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Research 67 8742-8751.
22. Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, Schwaninger R, Henriquez NV, ten Dijke P, Borovecki F, Markwalder R et al. 2007b BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. American Journal of Pathology 171 1047-1057.
23. Bunyaratavej P, Hullinger TG & Somerman MJ 2000 Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. Experimental Cell Research 260 324-333.
24. de Caestecker M 2004 The transforming growth factor-β superfamily of receptors. Cytokine and Growth Factor Reviews 15 1-11.
25. Canalis E, Economides AN & Gazzerro E 2003 Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 24 218-235.
26. Chang H, Brown CW & Matzuk MM 2002 Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocrine Reviews 23 787-823.
27. Cheng KH, Ponte JF & Thiagalingam S 2004 Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display. Cancer Research 64 1639-1646.
28. Cho KW, Kim JY, Song SJ, Farrell E, Eblaghie MC, Kim HJ, Tickle C & Jung HS 2006 Molecular interactions between Tbx3 and Bmp4 and amodel for dorsoventral positioning of mammary gland development. PNAS 103 16788-16793.
29. Clement JH, Sanger J & Hoffken K 1999 Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. International Journal of Cancer 80 250-256.
30. Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Hoffken K & Wolfl S 2000 Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. Journal of Cancer Research and Clinical Oncology 126 271-279.
31. Clement JH, Raida M, Sanger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A et al. 2005 Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. International Journal of Oncology 27 401-407.
32. Constam DB & Robertson EJ 1999 Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. Journal of Cell Biology 144 139-149.
33. Deng H, Makizumi R, Ravikumar TS, Dong H, Yang W & Yang WL 2007 Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Experimental Cell Research 313 1033-1044.
34. Derynck R & Zhang YE 2003 Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 577-584.
35. Derynck R, Akhurst RJ & Balmain A 2001 TGF-β signaling in tumor suppression and cancer progression. Nature Genetics 29 117-129.
36. ten Dijke P & Hill CS 2004 New insights into TGF-bβ-Smad signalling. Trends in Biochemical Sciences 29 265-273.
37. ten Dijke P, Goumans MJ, Itoh F & Itoh S 2002 Regulation of cell proliferation by Smad proteins. Journal of Cellular Physiology 191 1-16.
38. ten Dijke P, Korchynskyi O, Valdimarsdottir G & Goumans MJ 2003 Controlling cell fate by bone morphogenetic protein receptors. Molecular and Cellular Endocrinology 211 105-113.
39. Du J, Yang S, Wang Z, Zhai C, Yuan W, Lei R, Zhang J & Zhu T 2007 Bone morphogenetic protein 6 inhibit stress-induced breast cancer cells apoptosis via both smad and P38 pathways. Journal of Cellular Biochemistry 103 1584-1597.
40. Du J, Yang S, An D, Hu F, Yuan W, Zhai C & Zhu T 2009 BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Research 19 487-496.
41. Ducy P & Karsenty G 2000 The family of bone morphogenetic proteins. Kidney International 57 2207-2214.
42. Ebara S & Nakayama K 2002 Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27 S10-S15.
43. Feng XH & Derynck R 2005 Specificity and versatility in tgf-β signaling through Smads. Annual Review of Cell and Developmental Biology 21 659-693.
44. Gazzerro E & Canalis E 2006 Bone morphogenetic proteins and their antagonists. Reviews in Endocrine and Metabolic Disorders 7 51-65.
45. Gazzerro E & Minetti C 2007 Potential drug targets within bone morphogenetic protein signaling pathways. Current Opinion in Pharmacology 7 325-333.
46. Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL & Kreisberg J 2000a Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochimica et Biophysica Acta 1497 186-196.
47. Ghosh-Choudhury N, Woodruff K, QiW, Celeste A, Abboud SL & Ghosh Choudhury G 2000b Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochemical and Biophysical Research Communications 272 705-711.
48. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L & Choudhury GG 2002 Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. Journal of Biological Chemistry 277 33361-33368.
49. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI & Knaus P 2000 Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Molecular Biology of the Cell 11 1023-1035. (Pubitemid 30159319)
50. Gregory KE, Ono RN, Charbonneau NL, Kuo CL, Keene DR, Bachinger HP & Sakai LY 2005 The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. Journal of Biological Chemistry 280 27970-27980.
51. Griffith DL, Keck PC, Sampath TK, Rueger DC & Carlson WD 1996 Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. PNAS 93 878-883.
52. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC & Choe S 2002 Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420 636-642.
53. Gu K, Zhang L, Jin T & Rutherford RB 2004 Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells, Tissues, Organs 176 28-40.
54. Hanavadi S, Martin TA, Watkins G, Mansel RE & Jiang WG 2007 The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer. Annals of Surgical Oncology 14 2159-2166.
55. Harradine KA & Akhurst RJ 2006 Mutations of TGFb signaling molecules in human disease. Annals of Medicine 38 403-414.
56. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A & Massague J 2000 OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100 229-240. (Pubitemid 30064911)
57. Hay E, Lemonnier J, Fromigue O & Marie PJ 2001 Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. Journal of Biological Chemistry 276 29028-29036.
58. Heldin CH, Miyazono K & ten Dijke P 1997 TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390 465-471.
59. Helms MW, Packeisen J, August C, Schittek B, Boecker W, Brandt BH & Buerger H 2005 First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer. Journal of Pathology 206 366-376.
60. Herpin A & Cunningham C 2007 Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS Journal 274 2977-2985.
61. Hodgson JG, Chin K, Collins C & Gray JW 2003 Genome amplification of chromosome 20 in breast cancer. Breast Cancer Research and Treatment 78 337-345.
62. Hogan BL 1996a Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes and Development 10 1580-1594. (Pubitemid 26268864)
63. Hogan BL 1996b Bone morphogenetic proteins in development. Current Opinion in Genetics & Development 6 432-438.
64. Hsu MY, Rovinsky S, Penmatcha S, HerlynM& Muirhead D 2005 Bone morphogenetic proteins in melanoma: angel or devil? Cancer Metastasis Reviews 24 251-263.
65. Hu MC, Wasserman D, Hartwig S & Rosenblum ND 2004 p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. Journal of Biological Chemistry 279 12051-12059.
66. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA & Wozney JM 1996 Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13 291-300.
67. Itoh S, Itoh F, Goumans MJ & ten Dijke P 2000 Signaling of transforming growth factor-β family members through Smad proteins. European Journal of Biochemistry 267 6954-6967.
68. Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB & Stein GS 2005 Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. PNAS 102 1454-1459.
69. Javelaud D & Mauviel A 2005 Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 24 5742-5750.
70. Jin EJ, Lee SY, Choi YA, Jung JC, Bang OS & Kang SS 2006 BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Molecules and Cells 22 353-359.
71. de Jong DS, Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Wehrens R, Mummery CL, van Zoelen EJ, Olijve W & Steegenga WT 2004 Identification of novel regulators associated with early-phase osteoblast differentiation. Journal of Bone and Mineral Research 19 947-958.
72. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW & Waldman FM 1994 Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. PNAS 91 2156-2160. (Pubitemid 24092062)
73. Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K & Imamura T 2008 Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27 6322-6333.
74. Kawabata M, Imamura T & Miyazono K 1998 Signal transduction by bone morphogenetic proteins. Cytokine and Growth Factor Reviews 9 49-61. (Pubitemid 28280536)
75. Kelleher FC, Fennelly D & RaffertyM2006 Common critical pathways in embryogenesis and cancer. Acta Oncologica 45 375-388.
76. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ & Taichman RS 2001 Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Reviews 20 333-349.
77. Keski-Oja J, Koli K & von Melchner H 2004 TGF-β activation by traction? Trends in Cell Biology 14 657-659.
78. Ketolainen JM, Alarmo EL, Tuominen VJ & Kallioniemi A 2010 Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Research and Treatment [in press].
79. Kim IY & Kim SJ 2006 Role of bone morphogenetic proteins in transitional cell carcinoma cells. Cancer Letters 241 118-123.
80. Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK & Morton RA 2000 Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Research 60 2840-2844.
81. Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim SJ & Morton RA 2004 Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene 23 7651-7659.
82. Kimura N, Matsuo R, Shibuya H, Nakashima K & Taga T 2000 BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. Journal of Biological Chemistry 275 17647-17652.
83. Kingsley DM 1994 The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes and Development 8 133-146. (Pubitemid 2044355)
84. Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV & Blobe GC 2008 Bone morphogenetic proteins signal through the transforming growth factor-β type III receptor. Journal of Biological Chemistry 283 7628-7637.
85. Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Buchler MW & Korc M 1999 Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 116 1202-1216.
86. Korchynskyi O, Dechering KJ, Sijbers AM, Olijve W & ten Dijke P 2003 Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. Journal of Bone and Mineral Research 18 1177-1185.
87. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH & Moustakas A 2004 Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor b and bone morphogenetic protein. Molecular and Cellular Biology 24 4241-4254.
88. Kretzschmar M, Doody J & Massague J 1997 Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389 618-622.
89. Kusumegi T, Tanaka J, Kawano M, Yonemoto J, Tohyama C & Sone H 2004 BMP7/ActRIIB regulates estrogen-dependent apoptosis: new biomarkers for environmental estrogens. Journal of Biochemical and Molecular Toxicology 18 1-11.
90. Langenfeld EM, Bojnowski J, Perone J & Langenfeld J 2005 Expression of bone morphogenetic proteins in human lung carcinomas. Annals of Thoracic Surgery 80 1028-1032.
91. Langenfeld EM, Kong Y & Langenfeld J 2006 Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25 685-692.
92. Lee HJ, Liu H, Goodman C, Ji Y, Maehr H, Uskokovic M, Notterman D, Reiss M & Suh N 2006a Gene expression profiling changes induced by a novel Gemini vitamin D derivative during the progression of breast cancer. Biochemical Pharmacology 72 332-343.
93. Lee HJ, Wislocki A, Goodman C, Ji Y, Ge R, Maehr H, Uskokovic M, ReissM& Suh N 2006b A novel vitamin D derivative activates bone morphogenetic protein signaling in MCF10 breast epithelial cells. Molecular Pharmacology 69 1840-1848.
94. Leung-Hagesteijn C, Hu MC, Mahendra AS, Hartwig S, Klamut HJ, Rosenblum ND & Hannigan GE 2005 Integrin-linked kinase mediates bone morphogenetic protein 7-dependent renal epithelial cell morphogenesis. Molecular and Cellular Biology 25 3648-3657.
95. Liu F, Bloch N, Bhushan KR, De Grand AM, Tanaka E, Solazzo S, Mertyna PM, Goldberg N, Frangioni JV & Lenkinski RE 2008 Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Molecular Imaging 7 175-186.
96. Luo J, Sun MH, Kang Q, Peng Y, Jiang W, Luu HH, Luo Q, Park JY, Li Y, Haydon RC et al. 2005 Gene therapy for bone regeneration. Current Gene Therapy 5 167-179.
97. Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC & He TC 2007 Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. Journal of Orthopaedic Research 25 665-677.
98. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M & Wrana JL 1998 Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. Journal of Biological Chemistry 273 25628-25636.
99. Massague J 2003 Integration of Smad and MAPK pathways: a link and a linker revisited. Genes and Development 17 2993-2997.
100. Massague J & Gomis RR 2006 The logic of TGFβ signaling. FEBS Letters 580 2811-2820.
101. Massague J, Blain SW & Lo RS 2000 TGFb signaling in growth control, cancer, and heritable disorders. Cell 103 295-309.
102. Massague J, Seoane J & Wotton D 2005 Smad transcription factors. Genes and Development 19 2783-2810.
103. Masuda H, Fukabori Y, Nakano K, Shimizu N & Yamanaka H 2004 Expression of bone morphogenetic protein-7 (BMP-7) in human prostate. Prostate 59 101-106.
104. Miyazono K 2000 Positive and negative regulation of TGF-β signaling. Journal of Cell Science 113 1101-1109. (Pubitemid 30229527)
105. Miyazono K, Maeda S & Imamura T 2005 BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine and Growth Factor Reviews 16 251-263.
106. Montesano R 2007 Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth. Biochemical and Biophysical Research Communications 353 817-822.
107. Montesano R, Sarkozi R & Schramek H 2008 Bone morphogenetic protein-4 strongly potentiates growth factor-induced proliferation of mammary epithelial cells. Biochemical and Biophysical Research Communications 374 164-168.
108. Murakami G, Watabe T, Takaoka K, Miyazono K & Imamura T 2003 Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Molecular Biology of the Cell 14 2809-2817.
109. Newfeld SJ, Wisotzkey RG & Kumar S 1999 Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-β family ligands, receptors and Smad signal transducers. Genetics 152 783-795. (Pubitemid 29272728)
110. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI & Knaus P 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. Journal of Biological Chemistry 277 5330-5338.
111. Nohe A, Keating E, Knaus P & Petersen NO 2004 Signal transduction of bone morphogenetic protein receptors. Cellular Signalling 16 291-299.
112. Ong DB, Colley SM, Norman MR, Kitazawa S & Tobias JH 2004 Transcriptional regulation of a BMP-6 promoter by estrogen receptor a. Journal of Bone and Mineral Research 19 447-454.
113. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J & Niehrs C 1999 Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401 480-485. (Pubitemid 29470206)
114. Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J, Mukai T, Ogura T & Makino H 2007 Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. American Journal of Physiology. Renal Physiology 292 F1513-F1525.
115. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC & He TC 2003 Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. Journal of Cellular Biochemistry 90 1149-1165. (Pubitemid 37485051)
116. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH et al. 1996 Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122 2729-2737.
117. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F & Vescovi AL 2006 Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444 761-765.
118. Piscione TD, Phan T & Rosenblum ND 2001 BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. American Journal of Physiology. Renal Physiology 280 F19-F33. (Pubitemid 32473293)
119. Pouliot F & Labrie C 2002 Role of Smad1 and Smad4 proteins in the induction of p21WAF1, Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. Journal of Endocrinology 172 187-198.
120. Pouliot F, Blais A & Labrie C 2003 Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Research 63 277-281. (Pubitemid 36152479)
121. Raida M, Clement JH, Ameri K, Han C, Leek RD & Harris AL 2005a Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. International Journal of Oncology 26 1465-1470.
122. Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D & Harris AL 2005b Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. Journal of Cancer Research and Clinical Oncology 131 741-750.
123. Reddi AH 1997 Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine and Growth Factor Reviews 8 11-20.
124. Reddi AH 1998 Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature Biotechnology 16 247-252.
125. Reddi AH 2001 Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN. Arthritis Research 3 1-5.
126. Reinholz MM, Iturria SJ, Ingle JN & Roche PC 2002 Differential gene expression of TGF-β family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Research and Treatment 74 255-269.
127. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH & Miyazono K 1995 Cloning and characterization of a human type II receptor for bone morphogenetic proteins. PNAS 92 7632-7636.
128. Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL et al. 2005 DRAGON, a bone morphogenetic protein co-receptor. Journal of Biological Chemistry 280 14122-14129.
129. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH & Massague J 2007 Balancing BMP signaling through integrated inputs into the Smad1 linker. Molecular Cell 25 441-454.
130. Scherberich A, Tucker RP, Degen M, Brown-Luedi M, Andres AC & Chiquet-Ehrismann R 2005 Tenascin-W is found in malignant mammary tumors, promotes a8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-α induced expression in vitro. Oncogene 24 1525-1532.
131. Scherner O, Meurer SK, Tihaa L, Gressner AM & Weiskirchen R 2007 Endoglin differentially modulates antagonistic transforming growth factor-β1 and BMP-7 signaling. Journal of Biological Chemistry 282 13934-13943.
132. Schmierer B & Hill CS 2007 TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nature Reviews. Molecular Cell Biology 8 970-982.
133. Schwalbe M, Sanger J, Eggers R, Naumann A, Schmidt A, Hoffken K & Clement JH 2003 Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. International Journal of Oncology 23 89-95.
134. Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G, Lowik CW, Ackermann K, Pyerin W, Hamdy FC et al. 2007 Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. American Journal of Pathology 170 160-175.
135. Sebald W, Nickel J, Zhang JL & Mueller TD 2004 Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biological Chemistry 385 697-710.
136. Shi Y & Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 685-700.
137. Shibuya H, Iwata H, Masuyama N, Gotoh Y, Yamaguchi K, Irie K, Matsumoto K, Nishida E & Ueno N 1998 Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO Journal 17 1019-1028.
138. Shon SK, Kim A, Kim JY, Kim KI, Yang Y & Lim JS 2009 Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochemical and Biophysical Research Communications 385 198-203.
139. Siegel PM & Massague J 2003 Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Reviews. Cancer 3 807-821. (Pubitemid 37376979)
140. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE et al. 2006 Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. PNAS 103 14842-14847.
141. Sopory S, Nelsen SM, Degnin C, Wong C & Christian JL 2006 Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain. Journal of Biological Chemistry 281 34021-34031.
142. Steinert S, Kroll TC, Taubert I, Pusch L, Hortschansky P, Hoffken K, Wolfl S & Clement JH 2008 Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2. Journal of Cancer Research and Clinical Oncology 134 1237-1245.
143. Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H & Doihara H 2008 Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. Journal of Endocrinology 199 445-455.
144. Theriault BL, Shepherd TG, Mujoomdar ML & Nachtigal MW 2007 BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28 1153-1162.
145. Tsuchida K, Sunada Y, Noji S, Murakami T, Uezumi A & NakataniM2006 Inhibitors of the TGF-β superfamily and their clinical applications. Mini Reviews in Medicinal Chemistry 6 1255-1261.
146. Valcourt U, Kowanetz M, Niimi H, Heldin CH & Moustakas A 2005 TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Molecular Biology of the Cell 16 1987-2002.
147. Vessella RL & Corey E 2006 Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis. Clinical Cancer Research 12 6285s-6290s.
148. Waite KA & Eng C 2003a From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family. Nature Reviews. Genetics 4 763-773.
149. Waite KA & Eng C 2003b BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Human Molecular Genetics 12 679-684.
150. Wakefield LM, Piek E & Bottinger EP 2001 TGF-β signaling inmammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 6 67-82.
151. Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X, Yu Z, Gill GN & Andersen B 2007 The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 26 6431-6441.
152. Welsh J 2007 Vitamin D and prevention of breast cancer. Acta Pharmacologica Sinica 28 1373-1382.
153. Wilkinson L, Kolle G, Wen D, Piper M, Scott J & Little M 2003 CRIM1 regulates the rate of processing and delivery of bone morphogenetic proteins to the cell surface. Journal of Biological Chemistry 278 34181-34188.
154. Wozney JM 2002 Overview of bone morphogenetic proteins. Spine 27 S2-S8.
155. Wozney JM & Rosen V 1998 Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clinical Orthopaedics and Related Research 346 26-37.
156. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM & Wang EA 1988 Novel regulators of bone formation: molecular clones and activities. Science 242 1528-1534. (Pubitemid 19023695)
157. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H & Matsumoto K 1999 XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO Journal 18 179-187.
158. Yamamoto T, Saatcioglu F & Matsuda T 2002 Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology 143 2635-2642.
159. Yan W & Chen X 2007 Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells. Cancer Research 67 9117-9124.
160. Yang S, Zhong C, Frenkel B, Reddi AH & Roy-Burman P 2005 Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Research 65 5769-5777.
161. Yang S, Du J, Wang Z, Yuan W, Qiao Y, Zhang M, Zhang J, Gao S, Yin J, Sun B et al. 2007a BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer 7 211.
162. Yang X, Lee PJ, Long L, Trembath RC & Morrell NW 2007b BMP4 induces HO-1 via a Smad independent, p38MAPK dependent pathway in pulmonary artery myocytes. American Journal of Respiratory, Cell and Molecular Biology 37 598-605.
163. Yang S, Du J, Wang Z, Yan J, Yuan W, Zhang J & Zhu T 2009 Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer. International Journal of Biochemistry & Cell Biology 41 853-861.
164. Ye L, Lewis-Russell JM, Kyanaston HG & Jiang WG 2007 Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histology and Histopathology 22 1129-1147. (Pubitemid 47470307)
165. Yoshikawa H, Nakase T, Myoui A & Ueda T 2004 Bone morphogenetic proteins in bone tumors. Journal of Orthopaedic Science 9 334-340.
166. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F & Kalluri R 2003 BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine 9 964-968.
167. Zhang M, Yan JD, Zhang L, Wang Q, Lu SJ, Zhang J & Zhu TH 2005 Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Chinese Medical Journal 118 1629-1636. (Pubitemid 41489039)
168. Zhang M, Wang Q, Yuan W, Yang S, Wang X, Yan JD, Du J, Yin J, Gao SY, Sun BC et al. 2007 Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 105 91-97.
169. Zhao GQ 2003 Consequences of knocking out BMP signaling in the mouse. Genesis 35 43-56.
170. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG & Hidaka C 2006 Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 39 61-71.
171. Zwijsen A, Verschueren K & Huylebroeck D 2003 New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Letters 546 133-139.